Boehringer and Eli Lilly have received approval from the US FDA for Jardiance to...
Eisai and BioArctic’s Leqembi is the only approved treatment that slows cognitiv...
Pierre Fabre will fund the discovery and development of multiple small-molecule ...
The biopharma giant's decision to end its partnership with I-Mab follows it endi...
The Phase III trial of Luthathera as a first-line therapy showed improved progre...
China has granted approval for Henlius Biotech’s Hansizhuang for patients with o...
Glenmark Pharmaceuticals has signed a definitive agreement for the divestiture o...
Debiopharm and SunRock Biopharma have signed an agreement to advance the develop...
A Phase I trial exploring the gene therapy in patients with alpha-1 antitrypsin ...
The European Commission has approved Enrylaze for treating acute lymphoblastic l...
The WHO and the World Bank have published the 2023 UHC Global Monitoring Report,...
According to GlobalData, the number of individuals affected by rheumatoid arthri...
JURA Bio has entered into a research collaboration with Replay cell therapy prod...
The UK-based surgical robotics company has now raised over $1bn in funding, ceme...
The US Department of Defense grant is to study methylone for the rapid and long-...
Novo Holdings has acquired Paratek Pharmaceuticals for nearly $462m to bolster i...
